ArticleMolecular diversity2022

Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.

Mehrdad Sadafi Kohnehshahri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.